Simplex Trading »

Autolus Therapeutics Plc spon ads shares owned by Simplex Trading

Quarter-by-quarter ownership of Autolus Therapeutics Plc spon ads (AUTL) shares owned by Simplex Trading from 13F filings

Historical chart of Simplex Trading investment in Autolus Therapeutics Plc spon ads

Tip: Access up to 7 years of quarterly data

All positions including Autolus Therapeutics Plc spon ads held by Simplex Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Autolus Therapeutics Plc spon ads by Simplex Trading

Quarter filed Position value Share count Share price at filing
2024-09-30 $32k 8.8k 3.63
2024-06-30 $0 16 0.00
2024-03-31 $47k 7.4k 6.34
2023-12-31 $88k 14k 6.43
2023-09-30 $42k 18k 2.33

More positions owned by Simplex Trading

Spdr S&p 500 Etf Tr Put Put Option
Spdr S&p 500 Etf Tr Call Call Option
Invesco Qqq Tr Put Put Option
Nvidia Corporation Call Call Option
Nvidia Corporation Put Put Option
Invesco Qqq Tr Call Call Option
Ishares Tr Put Put Option
Ishares Tr Call Call Option
Apple Call Call Option
Tesla Call Call Option
Tesla Put Put Option
Select Sector Spdr Tr Put Put Option
Apple Put Put Option
Meta Platforms Call Call Option
Spdr Gold Tr Call Call Option

View all positions for Simplex Trading

Top funds holding Autolus Therapeutics Plc spon ads

Syncona Portfolio
Blackstone Group
Deep Track Capital
Polygon Management
Armistice Capital
Frazier Life Sciences Management
Affinity Asset Advisors
BlackRock
BlackRock
T. Rowe Price Associates
Deerfield Management Company
Laurion Capital Management
Morgan Stanley
Dr. Jeffrey R. Jay, M.D.
Stempoint Capital

View all funds holding Autolus Therapeutics Plc spon ads